Published in Virus Res on December 01, 1993
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol (1995) 1.77
Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission. J Virol (1998) 0.92
Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission. J Virol (1998) 0.86
Hepatitis C virus detection by single-round PCR specific for the terminal 3' noncoding region. J Clin Microbiol (1996) 0.78
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell (1981) 4.42
Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain. Cell (1982) 2.76
Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions. J Biol Chem (1980) 2.66
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol (1999) 2.37
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol (1995) 1.77
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J Virol (2000) 1.47
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Structure and replication of vaccinia virus telomeres. Cold Spring Harb Symp Quant Biol (1983) 1.36
A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. J Infect Dis (1987) 1.32
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. Proc Natl Acad Sci U S A (1985) 1.32
An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. Science (1989) 1.31
Mouse c-mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci U S A (1984) 1.30
Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J Virol (1986) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. J Virol (1989) 1.26
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. Virology (1999) 1.18
Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. Virology (1988) 1.17
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
tRNATrp (bovine) binding to the reverse transcriptase of avian myeloblastosis virus and function as a heterologous primer. Proc Natl Acad Sci U S A (1977) 1.08
Sequence homologies of diverse length tandem repetitions near ends of vaccinia virus genome suggest unequal crossing over. Nucleic Acids Res (1982) 1.06
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res (1989) 1.04
Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers. Antiviral Res (1989) 1.02
Measles antibody in previously immunized children. The need for revaccination. Am J Dis Child (1972) 1.02
Screening hospital patients for hepatitis B surface antigen. Am J Clin Pathol (1977) 1.01
Chronic hepatitis D virus (HDV) infection in hepatitis B virus carrier chimpanzees experimentally superinfected with HDV. J Infect Dis (1988) 1.00
Rubella: recent laboratory and clinical advances. Prog Med Virol (1966) 0.98
Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98
Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of gamma-globulin in preventing congenital rubella. Am J Dis Child (1965) 0.98
Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis (1975) 0.97
Protection of adults rechallenged with a human rotavirus. J Infect Dis (1990) 0.97
Fatal viral encephalitis in children with X-linked hypogammaglobulinemia. Am J Dis Child (1973) 0.96
Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. Am J Dis Child (1975) 0.96
Biologic and molecular genetic characteristics of a unique MCF virus that is highly leukemogenic in ecotropic virus-negative mice. Virology (1989) 0.95
Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees. Am J Dis Child (1969) 0.95
Rubella: studies on the natural disease. The significance of antibody status and communicability among young women. Am J Dis Child (1965) 0.94
Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis (1992) 0.94
Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis (1990) 0.93
Cross-genotypic interaction between hepatitis C virus NS3 protease domains and NS4A cofactors. J Hepatol (2000) 0.92
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91
Cell-mediated immunity in humans during viral infection: dermal hypersensitivity and in vitro lymphocyte proliferation during mild viral respiratory infections. Infect Immun (1974) 0.91
Riboprobe assay for HDV RNA: a sensitive method for the detection of the HDV genome in clinical serum samples. J Med Virol (1990) 0.90
Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90
Experimental rubella. Clinical and laboratory findings. Arch Intern Med (1965) 0.89
Influenza in ferrets and guinea pigs: effect on cell-mediated immunity. Infect Immun (1978) 0.88
Induction and persistence of local rotavirus antibodies in relation to serum antibodies. J Med Virol (1989) 0.87
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers. Vaccine (2001) 0.86
Challenge with rubella virus after loss of detectable vaccine-induced antibody. Rev Infect Dis (1985) 0.86
Evaluation of a live, attenuated recombinant influenza vaccine in high school children. Infect Immun (1975) 0.85
Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection? Arch Intern Med (1978) 0.85
Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella. Am J Dis Child (1969) 0.85
Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J Med Virol (1991) 0.85
Molecular cloning of the terminal hairpin of vaccinia virus DNA as an imperfect palindrome in an Escherichia coli plasmid. Gene (1985) 0.84
Structural requirements for binding of bovine tRNATrp with avian myeloblastosis virus DNA polymerase. Nucleic Acids Res (1980) 0.84
The prevalence of hepatitis C virus (HCV) in infants and children after liver transplantation. Dig Dis Sci (1994) 0.83
Experimental rubella in pregnant rhesus monkeys. J Infect Dis (1966) 0.83
Rubella control. Am J Dis Child (1971) 0.82
Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus. J Med Virol (1990) 0.82
Rubella vaccinees in a public school system: a four and one-half-year follow-up. Am J Dis Child (1974) 0.82
Herpesvirus hominis type 2 meningoencephalitis following renal transplantation. Am J Med (1976) 0.82
Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose. J Infect Dis (1984) 0.82
Comparison of class and subclass antibody response to live and UV-inactivated RSV administered intranasally in mice. J Med Virol (1991) 0.82
Salivary antibody titers in adults challenged with a human rotavirus. J Med Virol (1992) 0.81
Reye's syndrome. Annu Rev Med (1976) 0.81
Salicylate intoxication and influenza in ferrets. Pediatr Res (1979) 0.80
Oral ribavirin treatment of influenza A and B. Antimicrob Agents Chemother (1987) 0.80
Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition. Antiviral Res (1990) 0.80
The novel tertiary structure in delta RNA may function as a ribozyme control element. Prog Clin Biol Res (1991) 0.80
Rocky Mountain spotted fever in Clermont County, Ohio: description of an endemic focus. Am J Epidemiol (1973) 0.79
Follow-up studies of rubella vaccinees at adolescence. J Pediatr (1975) 0.78
A ribonuclease protection assay for the direct detection and quantitation of hepatitis C virus RNA. Clin Diagn Virol (1993) 0.78
Two-year follow-up of rubella vaccinees in a public school system. Am J Dis Child (1972) 0.78
Magnesium ion requirements for yeast enolase activity. Biochemistry (1977) 0.78